These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 24906341)

  • 41. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
    El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
    Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.
    Rybicki BA; Conti DV; Moreira A; Cicek M; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):23-9. PubMed ID: 14744728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.
    Chen S; Tang D; Xue K; Xu L; Ma G; Hsu Y; Cho SS
    Carcinogenesis; 2002 Aug; 23(8):1321-5. PubMed ID: 12151350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
    Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
    Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population.
    Yuan T; Deng S; Chen M; Chen W; Lu W; Huang H; Xia J
    Cancer Epidemiol; 2011 Apr; 35(2):170-4. PubMed ID: 20863780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
    Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
    Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA repair gene (XRCC1 and XPD) polymorphism and risk of primary ovarian failure.
    Kali Z; Cagiran FT; Kirici P; Dogan C; Celik O
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6593-6599. PubMed ID: 36196709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphisms in DNA repair genes and their association with risk of cervical cancer: A systematic review and meta-analysis.
    Shao X; Yang X; Liu Y; Song Q; Pan X; Chen W; Jiang W; Xu D; Song Y; Chen R
    J Obstet Gynaecol Res; 2022 Sep; 48(9):2405-2418. PubMed ID: 35732591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
    Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G
    PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Explore the genotype characteristics of DNA repair enzyme XRCC1 and XPD in the lens epithelium associated with free radical level in the age-related cataract patients].
    Wang X; Liu P; Li BH; Wu JL; Zhang MC
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):436-9. PubMed ID: 22932335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
    Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome.
    Joshi D; Korgaonkar S; Shanmukhaiah C; Vundinti BR
    Ann Hematol; 2016 Jan; 95(1):79-85. PubMed ID: 26482462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.
    Bănescu C; Trifa AP; Demian S; Benedek Lazar E; Dima D; Duicu C; Dobreanu M
    Biomed Res Int; 2014; 2014():213790. PubMed ID: 24955348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
    Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia.
    Seedhouse C; Bainton R; Lewis M; Harding A; Russell N; Das-Gupta E
    Blood; 2002 Nov; 100(10):3761-6. PubMed ID: 12393447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
    Du Y; He Y; Mei Z; Qian L; Shi J; Jie Z
    Clin Respir J; 2016 May; 10(3):311-7. PubMed ID: 25308691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XRCC1 and XPD polymorphisms: clinical outcomes and risk of prostate cancer in Bangladeshi population.
    Ahmed N; Islam MA; Hossain MM; Kabir Y
    Mol Biol Rep; 2024 Aug; 51(1):893. PubMed ID: 39115699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
    Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
    Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.